Rose Pharma, Inc. is a clinical-stage biopharmaceutical company developing a differentiated, short-acting GLP-1 designed to fill the critical market gap in weight loss maintenance, improved tolerability, and IBS pain reduction.  With a multi-billion dollar market opportunity, our Phase 2b asset offers a high-value commercial potential in the rapidly expanding GLP-1 space.  We are actively seeking corporate partnerships for development and commercialization of Rose10 in IBS pain and weight management.

Rose Pharma Inc.

Org chart

Teams

Offices